{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:41:55Z","timestamp":1791175315340,"version":"4.1.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/cad.0b013e328327994e","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T06:08:48Z","timestamp":1242886128000},"page":"334-345","source":"Crossref","is-referenced-by-count":59,"title":["Tranilast inhibits the growth and metastasis of mammary carcinoma"],"prefix":"10.1097","volume":"20","author":[{"given":"Rabindranath","family":"Chakrabarti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkateswaran","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Jothy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald J.","family":"Prud'homme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.clpt.6100449","article-title":"Advances in the treatment of breast cancer","volume":"83","author":"Moulder","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1476-5381.1976.tb08614.x","article-title":"Pharmacological properties of N-(dimethoxycinnamonyl) anthranilic acid (N-5\u2032), a new anti-atopic agent","volume":"58","author":"Azuma","year":"1976","journal-title":"Br J Pharmacol"},{"key":"R3-4-20210203","first-page":"141","article-title":"Tranilast, Kissei Pharmaceuticals","volume":"1","author":"Konneh","year":"1998","journal-title":"Idrugs"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000233800","article-title":"The inhibition mechanism of histamine release by N-(3\u2032, 4\u2032-dimethoxycinnamonyl) anthranilic acid","volume":"77","author":"Koda","year":"1985","journal-title":"Int Arch Aller Appl Immunol"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0021-5198(19)43349-0","article-title":"Study of the mechanism of inhibitory action of tranilast on chemical mediator release","volume":"46","author":"Komatsu","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-5198(19)32429-1","article-title":"The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts","volume":"60","author":"Suzawa","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1139\/y95-230","article-title":"Inhibitory effect of tranilast on proliferation, migration and collagen synthesis of human vascular smooth muscle cells","volume":"74","author":"Fukayama","year":"1996","journal-title":"Can J Physiol Pharmacol"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/oxfordjournals.jbchem.a124612","article-title":"Tranilast a selective inhibitor of collagen synthesis in human skin fibroblasts","volume":"116","author":"Yamada","year":"1994","journal-title":"J Biochem"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/labinvest.3700669","article-title":"Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations","volume":"87","author":"Prud'homme","year":"2007","journal-title":"Lab Invest"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jdiacomp.2004.02.002","article-title":"Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes","volume":"18","author":"Jones","year":"2004","journal-title":"J Diabet Complic"},{"issue":"4","key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1262-3636(07)70049-6","article-title":"Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes","volume":"29","author":"Bonnet","year":"2003","journal-title":"Diabetes Metab"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1097\/01.ASN.0000139066.77892.04","article-title":"Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model","volume":"15","author":"Kelly","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.ki.5000189","article-title":"Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells","volume":"69","author":"Qi","year":"2006","journal-title":"Kidney Int"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.ki.5000376","article-title":"Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model","volume":"69","author":"Kelly","year":"2006","journal-title":"Kidney Int"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ijc.1289","article-title":"N-(3\u2032, 4\u2032-dimethoxycinnamonyl) anthranilic acid (tranilast) transforming growth factor-\u03b2 release and reduces migration and invasiveness of human malignant glioma cells","volume":"93","author":"Platten","year":"2001","journal-title":"Int J Cancer"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1272\/jnms.69.224","article-title":"Anti-tumor effect of N-(3\u2032, 4\u2032-dimethoxycinnamonyl) anthranilic acid (tranilast) on experimental pancreatic cancer","volume":"69","author":"Hirori","year":"2002","journal-title":"J Nippon Med Sch"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1210\/jc.2002-020444","article-title":"Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21waf1 and p53","volume":"87","author":"Shime","year":"2002","journal-title":"J Clin Endocrino Metab"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1368-8375(02)00092-1","article-title":"Effect of fibroblast growth inhibitor on proliferation and metastasis of oral squamous cell carcinoma","volume":"39","author":"Noguchi","year":"2003","journal-title":"Oran Oncol"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1158\/0008-5472.CAN-05-3565","article-title":"Inhibition of pulmonary and skeletal metastasis by transforming growth factor-\u03b2 type I receptor kinase inhibitor","volume":"66","author":"Bandyopadhyay","year":"2006","journal-title":"Cancer Res"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1158\/1078-0432.CCR-06-0162","article-title":"Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-\u03b2 type I receptor kinase in vivo","volume":"12","author":"Ge","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8","article-title":"Invasion and metastasis of a mammary tumor involves TGF-\u03b2 signaling","volume":"91","author":"McEarchern","year":"2001","journal-title":"Int J Cancer"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-\u03b2 signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastasis development","volume":"103","author":"Yin","year":"1999","journal-title":"J Clin Invest"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4161\/cbt.4.3.1566","article-title":"Targeting TGF beta signaling for cancer therapy","volume":"4","author":"Iyer","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1517\/13543784.14.6.629","article-title":"TGF-beta inhibitors for the treatment of cancer","volume":"14","author":"Lahn","year":"2005","journal-title":"Expert Opin Invest Drugs"},{"key":"R25-4-20210203","first-page":"1486","article-title":"Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines","volume":"58","author":"Pulaski","year":"1998","journal-title":"Cancer Res"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1073\/pnas.0703071104","article-title":"The properties of a mammary gland cancer stem cell","volume":"104","author":"Zucchi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1016\/j.vaccine.2005.05.002","article-title":"A mutant B7-1\/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity","volume":"23","author":"Chakrabarti","year":"2005","journal-title":"Vaccine"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ymthe.2006.03.021","article-title":"Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand","volume":"14","author":"Glinka","year":"2006","journal-title":"Mol Ther"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/clim.2000.4964","article-title":"The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo","volume":"98","author":"Beshay","year":"2001","journal-title":"Clin Immunol"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The ki-67 protein: from the known to the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility","volume":"8","author":"Schmierer","year":"2007","journal-title":"Nat Rev"},{"key":"R32-4-20210203","first-page":"153","article-title":"Mitogen-activated protein kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocrine Rev"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bjc.6602051","article-title":"Dual blockade of EGFR and ERK1\/2 phosphorylation potentiates growth inhibition of breast cancer cells","volume":"91","author":"Lev","year":"2004","journal-title":"Br J Cancer"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1210\/me.2004-0082","article-title":"Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1\/2 on cancer cell proliferation","volume":"18","author":"Steinmetz","year":"2004","journal-title":"Mol Endocrinol"},{"key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000101313","article-title":"Smad4-independent TGF-b signaling in tumor cell migration","volume":"185","author":"Giehl","year":"2007","journal-title":"Cell Tissues Organs"},{"key":"R36-4-20210203","first-page":"419","article-title":"The TGF-\u03b2 family","author":"Zhang","year":"2008"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1210\/jc.2002-020444","article-title":"Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21(waf1) and p53","volume":"87","author":"Shime","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1189\/jlb.0208090","article-title":"Neuropilin-1 is a receptor for transforming growth factor \u03b2-1, activates its latent form, and promotes regulatory T cell activity","volume":"84","author":"Glinka","year":"2008","journal-title":"J Leuko Biol"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","article-title":"TGF-beta and epithelial-to-mesenchymal transitions","volume":"24","author":"Zavadil","year":"2005","journal-title":"Oncogene"},{"key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI24399","article-title":"Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis","volume":"115","author":"Han","year":"2005","journal-title":"J Clin Invest"},{"key":"R41-4-20210203","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1593\/neo.04241","article-title":"Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro","volume":"6","author":"Xie","year":"2004","journal-title":"Neoplasia"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1038\/sj.onc.1210414","article-title":"The ERK1\/2 mitogen-activated protein kinase pathway as the master regulator of G1 to S-phase transition","volume":"26","author":"Meloche","year":"2007","journal-title":"Oncogene"},{"key":"R43-4-20210203","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cytogfr.2006.07.002","article-title":"Cytokines in breast cancer","volume":"17","author":"Nicolini","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"R44-4-20210203","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2741\/2840","article-title":"The characterization and role of regulatory T cells in immune reactions","volume":"13","author":"Wilczynski","year":"2008","journal-title":"Front Biosci"},{"key":"R45-4-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"R46-4-20210203","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/0008-5472.CAN-08-0206","article-title":"Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17","volume":"68","author":"Nam","year":"2008","journal-title":"Cancer Res"},{"key":"R47-4-20210203","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1527-3466.1998.tb00359.x","article-title":"Tranilast: a new application in the cardiovascular field as an antiproliferative drugs","volume":"16","author":"Isaji","year":"1998","journal-title":"Cardiovascular Drug Rev"},{"key":"R48-4-20210203","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of prevention of restenosis with tranilast and its outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"key":"R49-4-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0378-4347(85)80171-7","article-title":"Simultaneous determination of tranilast and metabolites in plasma and urine using high-performance liquid chromatography","volume":"345","author":"Slobodzian","year":"1985","journal-title":"J Chromatogr"},{"key":"R50-4-20210203","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0021-9150(98)00308-6","article-title":"Tranilast inhibits the proliferation of human coronary smooth muscle cell through the activation of p21waf1","volume":"143","author":"Kusama","year":"1999","journal-title":"Atherosclerosis"},{"key":"R51-4-20210203","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1158\/0008-5472.CAN-08-0215","article-title":"An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments","volume":"68","author":"Nam","year":"2008","journal-title":"Cancer Res"},{"key":"R52-4-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11373-007-9201-3","article-title":"Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice","volume":"15","author":"Li","year":"2008","journal-title":"J Biomed Sci"},{"key":"R53-4-20210203","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbrc.2008.05.080","article-title":"Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells","volume":"372","author":"Du","year":"2008","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e328327994e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:01:34Z","timestamp":1786039294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200906000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328327994e","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}